Emerald Mutual Fund Advisers Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-832	Closed	-$121K	–	235
2020 Q3	$121K	Sell	832 -15	-2%	-$2.13K	0.01%	254
2020 Q2	$125K	Buy	+847	New	+$114K	0.01%	248
2020 Q1	–	Sell	-1,002	Closed	-$115K	–	224
2019 Q4	$115K	Buy	+1,002	New	+$99.9K	﹤0.01%	219
2015 Q2	–	Sell	-3,964	Closed	-$415K	–	256
2015 Q1	$415K	Sell	3,964 -162,404	-98%	-$16.5M	0.03%	198
2014 Q4	$16.1M	Sell	166,368 -45,319	-21%	-$4.2M	1.4%	13
2014 Q3	$16.5M	Sell	211,687 -10,914	-5%	-$704K	1.58%	8
2014 Q2	$14.1M	Buy	222,601 +9,640	+5%	+$573K	1.29%	16
2014 Q1	$14.3M	Sell	212,961 -141,711	-40%	-$11M	1.37%	11
2013 Q4	$26.4M	Buy	354,672 +124,595	+54%	+$7.43M	1.57%	9
2013 Q3	$14.7M	Buy	230,077 +15,440	+7%	+$770K	2.03%	4
2013 Q2	$6.65M	Buy	+214,637	New	+$5.71M	1.13%	28